GSOR06   Presentation Time: 12:25 PM

Following the treatment of locally advanced cervical cancer (LACC) with chemoradiation (CRT) and brachytherapy (BT), the evaluation of treatment response using positron-emission tomography (PET) is commonly used. It is unclear, however, whether indeterminate or equivocal PET response at 3 months on radiologist reading within the high risk clinical target volume (HRCTV) correlates to ongoing treatment response versus persistent disease.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research